Biochem/physiol Actions
Mubritinib (TAK-165) is a potent and selective inhibitor of the human epidermal growth factor receptor 2 ErbB (HER2) tyrosine kinase. Mubritinib potently inhibits proliferation of cancer cell lines over- expressing ErbB2.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: